mRNA expression of insulin-like growth factor-I (IGF-I) is suppressed and those of IGF-II and IGF-binding protein-1 are constantly expressed in the endometrium during use of an intrauterine levonorgestrel system

被引:32
作者
Rutanen, EM [1 ]
Salmi, A [1 ]
Nyman, T [1 ]
机构
[1] MINERVA FDN,HELSINKI,FINLAND
关键词
endometrium; IGFs; IGFBP-1; levonorgestrel; mRNA;
D O I
10.1093/molehr/3.9.749
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Insulin-like growth factors (IGF-I and IGF-II) are believed to mediate and modulate steroid hormone actions in the endometrium. In this study we determined the effects of an intrauterine system (IUS), releasing 20 mu g levonorgestrel (LNG) daily, on endometrial expression of mRNAs encoding IGFs and insulin-like growth factor binding protein (IGFBP)-1. In Northern blotting, IGF-I mRNA was undetectable in all endometrial specimens from women with an LNG-IUS (n = 11) and in pregnancy decidua, whereas several transcripts of 0.6-7.6 kb were detected in proliferative and secretory phase endometria. In contrast, mRNAs encoding lGF-II and IGFBP-1 were strongly expressed in pregnancy and in all endometrial samples from women with an LNG-IUS, but were undetectable in proliferative or early to mid-secretory phase endometria. Using the more sensitive reverse transcriptase-polymerase chain reaction (RT-PCR) method, IGF-I and IGF-II mRNAs were detectable in all cycling endometria, in early pregnancy decidua and in LNG-exposed endometrium. IGFBP-1 mRNA was constantly expressed in LNG-exposed endometrium, in early pregnancy decidua and in premenstrual endometrium, but was undetectable! in all specimens from proliferative or early to mid-secretory endometrium. Our data demonstrate that progestin treatment can affect the gene expression of endometrial growth factors in vivo. The consistent expression of mRNAs encoding IGF-II and IGFBP-1, with suppression of IGF-I mRNA in endometria exposed to LNG, suggests that this mode of hormone treatment can inhibit IGF-I action in the endometrium. If IGF-I mediates and modulates oestrogen action, suppression of IGF-I mRNA may be one of the molecular mechanisms which;accounts for the antiproliferative effects of progestogens on oestrogen-primed endometrium and the atrophy of endometrial epithelium resulting from use of an LNG-IUS.
引用
收藏
页码:749 / 754
页数:6
相关论文
共 43 条
[41]   Insulin-like growth factor-binding protein-1: A biochemical marker of endometrial response to progestin during hormone replacement therapy [J].
SuvantoLuukkonen, E ;
Sundstrom, H ;
Penttinen, J ;
Kauppila, A ;
Rutanen, EM .
MATURITAS, 1995, 22 (03) :255-262
[42]  
UMAYAHARA Y, 1994, J BIOL CHEM, V269, P16433
[43]   INSULIN-LIKE GROWTH-FACTOR SYSTEM GENE-EXPRESSION IN HUMAN ENDOMETRIUM DURING THE MENSTRUAL-CYCLE [J].
ZHOU, J ;
DSUPIN, BA ;
GIUDICE, LC ;
BONDY, CA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1723-1734